Sickle Cell/Hemoglobin Disease and Trait Management
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Mississippi State Department of Health, through its Genetics Bureau, is seeking qualified providers to deliver comprehensive, patient-centered care for individuals diagnosed with Sickle Cell Disease and Sickle Cell Trait, in alignment with state statutes mandating newborn screening and follow-up for heritable conditions. This initiative ensures early detection, timely intervention, and lifelong management for affected newborns and individuals across Mississippi, reinforcing public health outcomes through coordinated, evidence-based services. The solicitation emphasizes continuity of care, culturally competent support, and integration with existing state healthcare systems to improve quality of life and reduce complications associated with these conditions. Bidders must respond by July 31, 2026, and proposals should demonstrate experience in managing hemoglobin disorders, ability to reach underserved populations, and capacity for data reporting and longitudinal patient tracking. The contract will be managed by the Genetic Screening program based in Jackson, Mississippi, with primary point of contact Tracie Bryant, Director of the Genetics Bureau, and secondary contact Hannah Wright, Procurement Officer II. Performance is expected statewide to serve all Mississippi residents requiring care for Sickle Cell Disease or Trait, with a focus on equitable access, education, and lifelong health support across the continuum of care.
General Info
Agency
NAICS
Place of Performance
MS, USASet-Aside
Timeline
Response Deadline
